{
  "meta": {
    "title": "Ini_Cet_May_2024",
    "url": "https://brainandscalpel.vercel.app/ini-cet-may-2024-56294844.html",
    "scrapedAt": "2025-11-30T07:35:18.088Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Ruptured ectopic pregnancy</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Pelvic inflammatory disease</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian torsion</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemorrhagic corpus luteum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female in her reproductive age complains of abdominal pain associated with vaginal bleeding after 6 weeks of amenorrhea. USG shows free fluid in the peritoneum. She is hypotensive and has tachycardia. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1317715",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317715,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Choice A) Ruptured ectopic pregnancy (Correct Answer)</strong></p>\r\n<ul>\r\n<li><strong>Key Features:</strong>\r\n<ul>\r\n<li><strong>History of amenorrhea (6 weeks)</strong></li>\r\n<li><strong>Abdominal pain + vaginal bleeding</strong></li>\r\n<li><strong>USG: Free fluid in the peritoneum (suggesting hemoperitoneum)</strong></li>\r\n<li><strong>Hypotension + tachycardia (signs of hemorrhagic shock)</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Rationale:</strong>\r\n<ul>\r\n<li>A <strong>ruptured ectopic pregnancy</strong> typically presents with <strong>sudden-onset severe pain, hemodynamic instability, and hemoperitoneum</strong> due to rupture of the fallopian tube.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Choice B) Pelvic inflammatory disease (PID) (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Key Features of PID:</strong>\r\n<ul>\r\n<li>Gradual onset of lower abdominal pain</li>\r\n<li>Fever, mucopurulent cervical discharge</li>\r\n<li>Cervical motion tenderness (Chandelier sign)</li>\r\n</ul>\r\n</li>\r\n<li><strong>Why Incorrect?</strong>\r\n<ul>\r\n<li>PID <strong>does not</strong> cause hemoperitoneum or hemodynamic instability.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Choice C) Ovarian torsion (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Key Features of Ovarian Torsion:</strong>\r\n<ul>\r\n<li>Sudden, severe <strong>unilateral</strong> pelvic pain</li>\r\n<li>Associated with nausea &amp; vomiting</li>\r\n<li><strong>USG: Enlarged ovary with absent Doppler flow</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Why Incorrect?</strong>\r\n<ul>\r\n<li>Ovarian torsion <strong>does not</strong> present with vaginal bleeding or hemoperitoneum.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Choice D) Hemorrhagic corpus luteum (Incorrect)</strong></p>\r\n<ul>\r\n<li><strong>Key Features:</strong>\r\n<ul>\r\n<li>Sudden lower abdominal pain in the luteal phase</li>\r\n<li><strong>USG: Complex ovarian cyst with internal echoes (blood clot)</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Why Incorrect?</strong>\r\n<ul>\r\n<li>Unlike a ruptured ectopic pregnancy, hemorrhagic corpus luteum rupture <strong>rarely causes massive hemoperitoneum</strong> leading to <strong>shock</strong>.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key takeaway:</strong> A ruptured ectopic pregnancy is a life-threatening emergency requiring prompt diagnosis &amp; immediate surgical intervention (laparotomy/laparoscopy).</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Labetalol, steroid and deliver</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Give one dose of steroid, deliver at 37 weeks</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Labetalol & deliver immediately</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Labetalol + MgSO4 and deliver</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman at 36 weeks of gestation with chronic hypertension - 170/100 mm Hg, now complains of headache & visual disturbances. What is the management of choice in this case?</span></p>",
      "unique_key": "DT1317731",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317731,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Choice A)</strong> IV Labetalol, steroid, and deliver</p>\r\n<p><strong>Incorrect</strong> - While <strong>IV Labetalol</strong> is appropriate for BP control, steroids for fetal lung maturity are <strong>not needed after 34 weeks</strong>. More importantly, this option does <strong>not include MgSO4</strong>, which is required for seizure prophylaxis in <strong>severe preeclampsia</strong>.</p>\r\n<p><strong>Choice B)</strong> Give one dose of steroid, deliver at 37 weeks</p>\r\n<p><strong>Incorrect</strong> - The patient has <strong>severe preeclampsia</strong> (hypertension + headache &amp; visual symptoms), which <strong>requires urgent delivery</strong> after maternal stabilization. <strong>Delaying delivery to 37 weeks is inappropriate.</strong></p>\r\n<p><strong>Choice C)</strong> IV Labetalol &amp; deliver immediately</p>\r\n<p><strong>Incorrect</strong> - While <strong>IV Labetalol</strong> is needed for BP control and <strong>immediate delivery</strong> is indicated, <strong>this option does not include MgSO4</strong>, which is necessary to prevent eclampsia.</p>\r\n<p><strong>Choice D)</strong> IV Labetalol + MgSO4 and deliver</p>\r\n<p><strong>Correct</strong> - The patient has <strong>severe preeclampsia (hypertension &ge;160/110 mmHg + symptoms like headache &amp; visual disturbances)</strong>, requiring:</p>\r\n<ul>\r\n<li><strong>IV Labetalol (or Hydralazine/Nifedipine)</strong> for BP control</li>\r\n<li><strong>IV MgSO4</strong> for seizure prophylaxis</li>\r\n<li><strong>Urgent delivery</strong>, as the risks of continuing the pregnancy outweigh the benefits at 36 weeks</li>\r\n</ul>\r\n<p><strong>Key takeaway:</strong> BP control, seizure prophylaxis and urgent delivery are the sheet anchors in management of severe preeclampsia.</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Anomaly scan</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal free DNA testing</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Amniocentesis</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Chorionic villi sampling</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24 year old lady presented to the clinic with a quadruple screening test report showing high risk of NTD and low risk of trisomy. What is the next step of advice for this patient?</span></p>",
      "unique_key": "DT1317732",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317732,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Choice A)</strong> Anomaly scan (Level II ultrasound) (Correct Answer)</p>\r\n<ul>\r\n<li><strong>Correct</strong> - The <strong>next step</strong> for a high-risk NTD result on quadruple screening is a <strong>detailed fetal anomaly scan</strong> (preferably at <strong>18-22 weeks</strong>), which can directly visualize NTDs (e.g., <strong>spina bifida, anencephaly</strong>).</li>\r\n<li>Measurement of <strong>fetal alpha-fetoprotein (AFP)</strong> in <strong>amniotic fluid</strong> can be considered later if necessary.</li>\r\n</ul>\r\n<p><strong>Choice B</strong>) Fetal free DNA testing (Incorrect)</p>\r\n<ul>\r\n<li><strong>Wrong</strong> - Cell-free fetal DNA (cffDNA) testing is used primarily for <strong>aneuploidy screening (trisomy 21, 18, 13)</strong>. It <strong>does not detect neural tube defects</strong>.</li>\r\n</ul>\r\n<p><strong>Choice C</strong>) Amniocentesis (Incorrect)</p>\r\n<ul>\r\n<li><strong>Wrong - Amniocentesis</strong> is <strong>not the first step</strong> for suspected <strong>NTDs</strong>.</li>\r\n<li>It may be used <strong>later</strong> to measure <strong>amniotic fluid AFP (AFAFP) and acetylcholinesterase levels</strong>, but an <strong>anomaly scan is the initial step</strong>.</li>\r\n</ul>\r\n<p><strong>Choice D</strong>) Chorionic villus sampling (CVS) (Incorrect)</p>\r\n<ul>\r\n<li><strong>Wrong</strong> - CVS is used for <strong>chromosomal analysis (trisomies, single-gene disorders)</strong> but is <strong>not useful for diagnosing NTDs</strong>.</li>\r\n</ul>\r\n<p><strong>Key takeaway:</strong> Anomaly scan at 18-22 weeks is a promising tool to detect suspected NTDs.</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboprost</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Methergine</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostaglandin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following drugs is avoided in hypertensive females with PPH?</span></p>",
      "unique_key": "DT1317733",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317733,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Choice A) Carboprost (15-methyl PGF2&alpha;)</strong> - This is a prostaglandin analog (PGF2&alpha;) that causes <strong>uterine contraction</strong> and is <strong>used in PPH</strong>, but it can cause <strong>bronchospasm</strong> and should be <strong>cautiously used in asthma</strong>. However, it is not contraindicated in hypertension.</p>\r\n<p><strong>Choice B) Oxytocin</strong> - This is the <strong>first-line drug</strong> for PPH management. It causes <strong>uterine contraction</strong> without significantly raising blood pressure, so it is <strong>safe in hypertensive patients</strong>.</p>\r\n<p><strong>Choice C) Methergine (Methylergometrine)</strong> - This is an <strong>ergot alkaloid</strong> that strongly <strong>contracts the uterus</strong>, but it also causes <strong>vasoconstriction</strong>, which can <strong>worsen hypertension</strong>. It is <strong>contraindicated in hypertensive women</strong> due to the risk of <strong>hypertensive crisis and stroke</strong>.</p>\r\n<p><strong>Choice D) Prostaglandin (PGE1)</strong> - Prostaglandins like <strong>Misoprostol (PGE1) and D</strong> <strong>used for PPH</strong>, but they do not cause <strong>significant hypertension</strong>.</p>\r\n<p><strong>Key takeaway:</strong> Methergine is to be avoided for PPH management in women with hypertension as it causes severe vasoconstriction and may precipitate a hypertensive crisis.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Baby is O +ve & DCT is negative</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">All cases, no exception</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Baby is O -ve & DCT is +ve</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Baby is O +ve & DCT is +ve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A G2P1L1 delivered a baby via full term vaginal delivery. Patient was found to be O negative and her husband's blood group was found to be B positive. She was given anti-d at 28 weeks of gestation. Which of the following is the appropriate situation to administer postpartum anti-D prophylaxis?</span></p>",
      "unique_key": "DT1317734",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317734,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Choice A) Baby is O-positive &amp; Direct Coombs Test (DCT) is negative - Correct Answer</strong></p>\r\n<ul>\r\n<li>Postpartum <strong>anti-D prophylaxis</strong> is required <strong>only if the baby is Rh-positive</strong> to prevent maternal alloimmunization.</li>\r\n<li>Since the <strong>baby is O-positive and DCT is negative</strong>, there is no <strong>already established alloimmunization</strong>, and <strong>anti-D should be given within 72 hours of delivery</strong>.</li>\r\n</ul>\r\n<p><strong>Choice B) All cases, no exception</strong> - Incorrect</p>\r\n<ul>\r\n<li><strong>Anti-D is not needed if the baby is Rh-negative</strong> because there is <strong>no risk of maternal alloimmunization</strong> in that case.</li>\r\n</ul>\r\n<p><strong>Choice C) Baby is O-negative &amp; DCT is positive</strong> - Incorrect</p>\r\n<ul>\r\n<li>If the <strong>baby is Rh-negative</strong>, then <strong>anti-D is not required</strong> as maternal alloimmunization will not occur.</li>\r\n<li><strong>DCT positivity</strong> suggests <strong>maternal antibodies are already present</strong>, making <strong>anti-D administration irrelevant</strong>.</li>\r\n</ul>\r\n<p><strong>Choice D) Baby is O-positive &amp; DCT is positive</strong> - Incorrect</p>\r\n<ul>\r\n<li>If the <strong>DCT is positive</strong>, it means maternal <strong>anti-D antibodies have already crossed the placenta</strong>, suggesting <strong>sensitization has occurred</strong>.</li>\r\n<li>In this case, <strong>anti-D prophylaxis is ineffective</strong>, as the immune response has already been triggered.</li>\r\n</ul>\r\n<p><strong>Key takeaway:</strong> Postpartum <strong>anti-D prophylaxis</strong> is required <strong>only if the baby is Rh-positive &amp; Direct Coombs Test</strong> is negative to prevent maternal alloimmunization.</p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexa 6mg 12 hours 4 doses</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta 12 mg 12 hours 2 doses</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexa 6 mg 24 hours 4 doses</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta 12 mg 12 hours 4 doses</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Correct dose of antenatal steroid for lung maturity</span></p>",
      "unique_key": "DT1317735",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317735,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>For <strong>dexamethasone</strong>, the standard regimen is:</p>\r\n<ul>\r\n<li><strong>6 mg every 12 hours for 4 doses</strong> (total of 24 mg). This is the <strong>recommended protocol</strong> for improving lung maturity in preterm infants.</li>\r\n</ul>\r\n<p><strong>Incorrect choices explanation:</strong></p>\r\n<p><strong>Choice B) Beta 12 mg every 12 hours for 2 doses</strong> - The standard dose for betamethasone is 12 mg every 24 hours for 2 doses.</p>\r\n<p><strong>Choice C) Dexa 6 mg every 24 hours for 4 doses</strong> - This is not the standard dose. <strong>Dexamethasone</strong> should be given every <strong>12 hours</strong>.</p>\r\n<p><strong>Choice D) Beta 12 mg every 12 hours for 4 doses</strong> - This is an incorrect protocol for <strong>betamethasone</strong>. The correct dose is <strong>2 doses</strong>, not 4.</p>\r\n<p><strong>Key takeaway:</strong> Antenatal corticosteroids before 34 weeks of gestation accelerate fetal lung maturity.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Cabergoline</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Pramipexole</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Sumatriptan</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the appropriate medication to administer to a woman whose fetus is dead & who is presented with breast engorgement?</span></p>",
      "unique_key": "DT1317737",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317737,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Choice A: Cabergoline</strong> is a <strong>dopamine agonist</strong> that inhibits prolactin secretion. It is used to <strong>suppress lactation</strong> and relieve <strong>breast engorgement</strong> in situations like <strong>stillbirth</strong> or <strong>miscarriage</strong>, where lactation is not desired. It is effective in reducing milk production and associated discomfort.</li>\r\n</ul>\r\n<p><strong>Incorrect choices explanation: </strong></p>\r\n<ul>\r\n<li><strong>Choice B) Pramipexole:</strong> This is also a <strong>dopamine agonist</strong> used for <strong>Parkinson's disease</strong> and <strong>Restless Leg Syndrome</strong>. However, it is not used to suppress lactation.</li>\r\n<li><strong>Choice C) Sumatriptan:</strong> This is a <strong>serotonin agonist</strong> primarily used to treat <strong>migraine headaches</strong> and is not related to lactation suppression.</li>\r\n<li><strong>Choice D) Metoclopramide:</strong> This is a <strong>dopamine antagonist</strong> that actually <strong>increases prolactin levels</strong> and could potentially <strong>increase lactation</strong>, making it inappropriate for breast engorgement in a woman whose fetus has died.</li>\r\n</ul>\r\n<p><strong>Key takeaway:</strong> Dopamine agonist like cabergoline is used for lactation suppression.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Estradiol</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Estriol</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Conjugated estrogen</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is the most potent natural estrogen?</span></p>",
      "unique_key": "DT1317738",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317738,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Estradiol</strong> is the most potent and biologically active form of estrogen. It is produced primarily by the ovaries, especially during the reproductive years, and plays a key role in regulating the menstrual cycle and supporting the reproductive system.</li>\r\n</ul>\r\n<p><strong>Option-wise explanation:</strong></p>\r\n<ul>\r\n<li><strong>Choice A) Estradiol:</strong> As the most potent natural estrogen, estradiol has a significant effect on the growth and maintenance of female reproductive tissues and other estrogen-responsive tissues. It is the primary estrogen in premenopausal women.</li>\r\n<li><strong>Choice B) Estriol:</strong> Estriol is a weaker estrogen, mainly produced during pregnancy by the placenta. While it plays a role in the body, it is less potent than estradiol.</li>\r\n<li><strong>Choice C) Conjugated estrogen:</strong> This is a mixture of estrogens (mainly estrone sulfate) derived from the urine of pregnant mares. It is used in hormone replacement therapy (HRT), but it is not a naturally occurring estrogen in humans.</li>\r\n<li><strong>Choice D) Estrone:</strong> Estrone is another form of estrogen, but it is less potent than estradiol and is primarily produced after menopause.</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong> E2 or estradiol is the most potent estrogen present in reproductive aged women.</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin like growth factor</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hormones is not required for fetal growth?</span></p>",
      "unique_key": "DT1317739",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317739,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Growth hormone (GH)</strong> is not directly required for fetal growth. Although growth hormone plays a significant role in postnatal growth, fetal growth is primarily influenced by other hormones such as insulin, insulin-like growth factors (IGFs), and thyroid hormones.</li>\r\n</ul>\r\n<p><strong>Option-wise explanation:</strong></p>\r\n<ul>\r\n<li><strong>Choice A) Insulin:</strong> Insulin is crucial for fetal growth as it regulates glucose metabolism and promotes cell growth and differentiation, which are essential for fetal development.</li>\r\n<li><strong>Choice B) Insulin-like growth factor (IGF):</strong> IGFs are critical for fetal growth as they mediate the effects of growth hormone and contribute to cell division and tissue growth.</li>\r\n<li><strong>Choice C) Growth hormone:</strong> While growth hormone is important for postnatal growth and development, it does not play a direct role in fetal growth. Fetal growth is primarily regulated by insulin, IGF, and thyroid hormones rather than growth hormone.</li>\r\n<li><strong>Choice D) Thyroxine:</strong> Thyroxine is vital for fetal brain development and overall fetal growth. It helps in the maturation of various organ systems and metabolism.</li>\r\n</ul>\r\n<p><strong>Key takeaway:</strong> Primary factors involved in fetal growth are insulin, IGF &amp; Thyroxine, GH being an indirect contributor.</p>\r\n<p><strong>Reference:</strong> www.ncbi.com</p>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Estimated fetal weight < 3rd percentile</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal circumference less than 3rd percentile</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Absent diastolic flow in umbilical artery</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine artery PI < 95%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a criteria to diagnose IUGR?</span></p>",
      "unique_key": "DT1317740",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317740,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>To diagnose <strong>Intrauterine Growth Restriction (IUGR)</strong>, the following criteria are typically considered:</p>\r\n<ul>\r\n<li><strong>A) Estimated fetal weight &lt; 3rd percentile:</strong> This is a key criterion used to identify IUGR. If the estimated fetal weight falls below the 3rd percentile, the fetus is considered growth-restricted.</li>\r\n<li><strong>B) Abdominal circumference less than 3rd percentile:</strong> Abdominal circumference is another important measurement. A smaller abdominal circumference relative to gestational age is often used to diagnose IUGR.</li>\r\n<li><strong>C) Absent diastolic flow in umbilical artery:</strong> The absence of diastolic flow in the umbilical artery is indicative of abnormal placental blood flow, which is commonly associated with IUGR.</li>\r\n<li><strong>D) Uterine artery PI &lt; 95%:</strong> The <strong>pulsatility index (PI)</strong> in the uterine artery is used to assess placental blood flow. A low uterine artery PI (less than 95th percentile) would indicate good placental perfusion, which is typically not associated with IUGR. High uterine artery PI values (above the 95th percentile) are more commonly seen in pregnancies with IUGR, reflecting impaired placental perfusion.</li>\r\n</ul>\r\n<p>Therefore, the <strong>correct answer</strong> is <strong>D) Uterine artery PI &lt; 95%</strong>, as it is not typically used to diagnose IUGR.</p>\r\n<p><strong>Key takeaway:</strong> Uterine artery PI is a marker of placental perfusion and not a direct key criterion to diagnose FGR.</p>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Monochorionic monoamniotic</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Monochorionic diamniotic</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Monoamniotic dichorionic</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Dichorionic diamniotic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not possible?</span></p>",
      "unique_key": "DT1317741",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317741,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The different types of twin pregnancies are classified based on the number of <strong>chorions</strong> (placental sacs) and <strong>amnions</strong> (fluid sacs) present.</p>\r\n<ul>\r\n<li><strong>Choice A) Monochorionic monoamniotic:</strong> This is a possible scenario, where both twins share a single placenta (monochorionic) and are in the same amniotic sac (monoamniotic). This type of pregnancy has the highest risk for complications such as cord entanglement.</li>\r\n<li><strong>Choice B) Monochorionic diamniotic:</strong> This is also possible. In this type, the twins share a single placenta (monochorionic), but each is in its own amniotic sac (diamniotic). This is the most common form of monochorionic twins.</li>\r\n<li><strong>Choice C) Monoamniotic dichorionic:</strong> This is not possible. In a <strong>dichorionic</strong> pregnancy, each twin would have its own placenta, and they would be in separate amniotic sacs (diamniotic). It is not possible for both twins to be in the same amniotic sac (monoamniotic) while also having separate placentas (dichorionic).</li>\r\n<li><strong>Choice D) Dichorionic diamniotic:</strong> This is a possible and common situation. In this case, each twin has its own placenta (dichorionic) and is in its own amniotic sac (diamniotic). This is typical of dizygotic (fraternal) twins or the early division of a zygote in a monozygotic twin pregnancy.</li>\r\n</ul>\r\n<p><strong>Correct answer: C) Monoamniotic dichorionic</strong> is not possible.</p>\r\n<p><strong>Key takeaway:</strong> Mono Amnionicity is possible in monochorionic placentation, not in dichorionic placentation.</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Imperforate hymen</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Transverse vaginal septum</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Vertical vaginal septum</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian agenesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 18-year-old girl who was brought by her mother presented with primary amenorrhea and acute retention of urine. She had cyclical pain abdomen and on examination, a suprapubic mass and a tense bluish bulge was seen in her vagina. What is the most appropriate cause of her symptoms?</span></p>",
      "unique_key": "DT1317742",
      "question_audio": null,
      "question_video": null,
      "map_id": 1317742,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option-wise Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Choice A) Imperforate hymen (Correct Answer)</strong>\r\n<ul>\r\n<li><strong>Key Features:</strong>\r\n<ul>\r\n<li><strong>Primary amenorrhea</strong> in an adolescent with <strong>cyclical abdominal pain</strong>.</li>\r\n<li><strong>Acute retention of urine</strong> due to bladder distention from the <strong>mass effect</strong>.</li>\r\n<li><strong>Examination findings:</strong> A <strong>tense bluish bulge</strong> at the <strong>vaginal opening</strong>, indicative of <strong>hydrometrocolpos</strong> (accumulation of menstrual blood in the vagina and uterus due to an obstruction).</li>\r\n</ul>\r\n</li>\r\n<li><strong>Rationale:</strong>\r\n<ul>\r\n<li><strong>Imperforate hymen</strong> is the most common congenital cause of <strong>outflow tract obstruction</strong>. It presents with <strong>primary amenorrhea</strong> and <strong>cyclical abdominal pain</strong> due to <strong>accumulation of menstrual blood</strong>. The bluish bulge is caused by <strong>hydrometrocolpos</strong>.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice B) Transverse vaginal septum (Incorrect)</strong>\r\n<ul>\r\n<li><strong>Key Features:</strong>\r\n<ul>\r\n<li>Can cause <strong>primary amenorrhea</strong> with cyclical pain, but usually presents with a <strong>palpable vaginal mass</strong> upon examination, located higher in the vagina, not at the vaginal opening.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Why Incorrect?</strong>\r\n<ul>\r\n<li>While a transverse vaginal septum may cause a <strong>similar clinical picture</strong>, the <strong>bulge is not bluish</strong> at the vaginal opening, and a higher location of the obstruction in the vaginal canal makes it less likely.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice C) Vertical vaginal septum (Incorrect)</strong>\r\n<ul>\r\n<li><strong>Key Features:</strong>\r\n<ul>\r\n<li>This septum divides the vaginal canal into two <strong>longitudinal halves</strong>.</li>\r\n<li>Can lead to <strong>primary amenorrhea</strong> but would not present with a <strong>bluish bulge</strong> at the vaginal opening.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Why Incorrect?</strong>\r\n<ul>\r\n<li>Unlike an imperforate hymen, a <strong>vertical vaginal septum</strong> does not block the vaginal opening and is less likely to cause <strong>acute urinary retention</strong>.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice D) Mullerian agenesis (Incorrect)</strong>\r\n<ul>\r\n<li><strong>Key Features:</strong>\r\n<ul>\r\n<li>Also known as <strong>Mayer-Rokitansky-Kuster-Hauser syndrome</strong>, characterized by <strong>absent uterus</strong> and <strong>upper two-thirds of the vagina</strong>.</li>\r\n<li>Women with this condition typically have <strong>primary amenorrhea</strong>, but no cyclical pain, and <strong>vaginal bulge</strong> due to menstrual blood accumulation is not seen.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Why Incorrect?</strong>\r\n<ul>\r\n<li>In <strong>Mullerian agenesis</strong>, the <strong>vagina is absent or underdeveloped</strong>, so there would be no bulging at the vaginal opening and no accumulation of menstrual blood.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key takeaway:</strong> Imperforate hymen presents with cyclic abdominal pain, suprapubic bulge &amp; bluish bulge per vaginum.</p>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}